Cabot Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cabot stock.
View analyst ratings for Cabot or view top-rated stocks.

Wall Street analysts have given Cabot a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cabot wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Cabot saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 1,270,000 shares, a decrease of 34.5% from the June 30th total of 1,940,000 shares. Based on an average daily trading volume, of 486,000 shares, the days-to-cover ratio is presently 2.6 days. Currently, 2.3% of the company's shares are short sold.
View Cabot's Short Interest.

Cabot is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Cabot.

Cabot will be holding an earnings conference call on Tuesday, August 10th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Cabot Co. (NYSE:CBT) posted its earnings results on Sunday, May, 2nd. The specialty chemicals company reported $1.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.97 by $0.41. The specialty chemicals company had revenue of $842 million for the quarter, compared to analyst estimates of $771.05 million. Cabot had a negative net margin of 5.17% and a positive trailing twelve-month return on equity of 19.21%. The company's revenue was up 18.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.77 earnings per share.
View Cabot's earnings history.

Cabot's stock was trading at $29.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CBT shares have increased by 82.1% and is now trading at $54.48.
View which stocks have been most impacted by COVID-19.

Cabot declared a quarterly dividend on Friday, July 9th. Investors of record on Friday, August 27th will be given a dividend of $0.35 per share on Friday, September 10th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date of this dividend is Thursday, August 26th.
View Cabot's dividend history.

Cabot pays an annual dividend of $1.40 per share and currently has a dividend yield of 2.54%. Cabot does not yet have a strong track record of dividend growth. The dividend payout ratio of Cabot is 67.31%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cabot will have a dividend payout ratio of 26.97% next year. This indicates that Cabot will be able to sustain or increase its dividend.
View Cabot's dividend history.

Cabot updated its FY 2021 earnings guidance on Monday, May, 17th. The company provided EPS guidance of 4.700-4.950 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.070. The company issued revenue guidance of -.

7 brokers have issued 1 year target prices for Cabot's stock. Their forecasts range from $45.00 to $143.00. On average, they anticipate Cabot's stock price to reach $74.29 in the next twelve months. This suggests a possible upside of 36.4% from the stock's current price.
View analysts' price targets for Cabot or view top-rated stocks among Wall Street analysts.

40 employees have rated Cabot CEO Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among Cabot's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Cabot include LyondellBasell Industries (LYB), Westlake Chemical (WLK), Kronos Worldwide (KRO), Hawkins (HWKN), Koppers (KOP), Tredegar (TG) and Trecora Resources (TREC).
View all of CBT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and The Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include New York State Common Retirement Fund (0.83%), Alliancebernstein L.P. (0.23%), Cambiar Investors LLC (0.09%), Sensible Financial Planning & Management LLC. (0.04%), Ziegler Capital Management LLC (0.04%) and Oregon Public Employees Retirement Fund (0.03%). Company insiders that own Cabot stock include Hobart Kalkstein and Karen A Kalita.
View institutional ownership trends for Cabot.

CBT stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, State of Alaska Department of Revenue, State of Michigan Retirement System, New York State Common Retirement Fund, Arizona State Retirement System, and Sensible Financial Planning & Management LLC..
View insider buying and selling activity for Cabot or view top insider-selling stocks.

CBT stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Hillsdale Investment Management Inc., Advisors Asset Management Inc., Cornerstone Investment Partners LLC, New Mexico Educational Retirement Board, Boston Trust Walden Corp, Zurcher Kantonalbank Zurich Cantonalbank , and Carolina Wealth Advisors LLC.
View insider buying and selling activity for Cabot or or view top insider-buying stocks.

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $54.48.

Cabot has a market capitalization of $3.09 billion and generates $2.61 billion in revenue each year. The specialty chemicals company earns $-238,000,000.00 in net income (profit) each year or $2.08 on an earnings per share basis.

Cabot employs 4,500 workers across the globe.

The official website for Cabot is www.cabot-corp.com.

Cabot is headquartered at TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at (617) 345-0100 or via email at [email protected]